Robert Routley
Chief Executive Officer @ Acorn Capital
Robert Routley is a Series B investor at Acorn Capital focused on Software and Electronics. Robert Routley
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Robert Routley invests in
Stages Robert Routley invests in
Countries Robert Routley invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 1 (25%)
- Electronics 1 (25%)
- Health Care 1 (25%)
- Manufacturing 1 (25%)
- Health Diagnostics 1 (25%)
Stage
- Series B 2 (50%)
- Series A 1 (25%)
- Venture - Series Unknown 1 (25%)
Country
- Australia 1 (25%)
- United States 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Liquid Instruments develops software-defined test and measurement systems that enable engineers and scientists to perform complex experiments and signal analysis using a single, reconfigurable hardware platform. The company’s core offering is the Moku product line, which integrates multiple laboratory instruments, such as oscilloscopes, spectrumanalyzers, waveform generators, and lock-in amplifiers, into one device that can be configured and updated through software. Its platform is built on field-programmable gate arrays, allowing users to dynamically switch between instrument functions or combine multiple tools within the same system depending on testing requirements. This approach replaces traditional setups that rely on multiple standalone instruments, reducing equipment complexity, cost, and physical space while enabling customized configurations for different applications. | $8M / Venture - Series Unknown / Jun 19, 2024 | ||
| ImmVirX hopes to advance a new generation of cancer treatments,By developing a novel oncolytic immunotherapy that targets cancer indications with high unmet need | $25M / Series B / Jun 05, 2023 | ||
| Liquid Instruments develops software-defined test and measurement systems that enable engineers and scientists to perform complex experiments and signal analysis using a single, reconfigurable hardware platform. The company’s core offering is the Moku product line, which integrates multiple laboratory instruments, such as oscilloscopes, spectrumanalyzers, waveform generators, and lock-in amplifiers, into one device that can be configured and updated through software. Its platform is built on field-programmable gate arrays, allowing users to dynamically switch between instrument functions or combine multiple tools within the same system depending on testing requirements. This approach replaces traditional setups that rely on multiple standalone instruments, reducing equipment complexity, cost, and physical space while enabling customized configurations for different applications. | $28.5M / Series B / Sep 13, 2022 | ||
| ImmVirX hopes to advance a new generation of cancer treatments,By developing a novel oncolytic immunotherapy that targets cancer indications with high unmet need | $22M / Series A / May 14, 2021 |
Co-Investors
About Acorn Capital
Acorn Capital is a boutique investment manager that manages active VC and micro funds. It defines the public or listed microcap sector as those listed public companies that have market capitalizations less than the 250th largest company on the ASX. Acorn Capital’s research-driven investment process has been designed to take advantage ofinefficiencies that can exist in the microcap sector arising from poor information flows and the lack of liquidity. In contrast to the largest companies listed on the ASX, where there is a wealth of research and information, there is a relative lack of information on microcaps.
Acorn Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Ben Dalling
Investment Director
|
|||
|
Robert Routley
Chief Executive Officer
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Robert Routley invest in?
Robert Routley invests primarily in Software, Electronics and Health Care startups, most often at Series B and Series A stage. Most of the 4 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Robert Routley?
Public channels for Robert Routley include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Robert Routley last invest?
The most recent investment recorded for Robert Routley closed in Jun 2024. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
